Targeting Epigenetics through Histone Deacetylase Inhibitors in Acute Lymphoblastic Leukemia

E-ISSN： 1873-5576|11|7|882-893

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.11, Iss.7, 2011-09, pp. : 882-893

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Histone Deacetylase Inhibitors for Anti-Malarial Therapy

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 3, 2009-02 ,pp. : 292-308

Bentham Science Publishers

Access to resources Recommend Favorite

Exploiting Epigenetics to Eliminate Cancer: Histone Deacetylase Inhibitors Head Towards the Clinic

By Adis International Limited

Pharmaceutical & Diagnostic Innovation, Vol. 4, Iss. 8, 2006-01 ,pp. : 7-10

Adis International

Access to resources Recommend Favorite

A Mechanistic Approach to Anticancer Therapy: Targeting the Cell Cycle with Histone Deacetylase Inhibitors

Current Pharmaceutical Design, Vol. 11, Iss. 9, 2005-01 ,pp. : 1091-1104

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Cancer and Neuropathy with Histone Deacetylase Inhibitors:Two Birds with One Stone?

Current Cancer Drug Targets, Vol. 8, Iss. 4, 2008-06 ,pp. : 266-274

Bentham Science Publishers

Access to resources Recommend Favorite

Histone deacetylase inhibitors

By Price Steve Dyke Hazel J

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 7, 2007-07 ,pp. : 745-765

Informa Healthcare

Access to resources Recommend Favorite